콘텐츠로 이동

지역별 접근성

This is one of the most critical pages on Yakuten. For many in the transgender community, the problem isn’t “which medication should I choose”; it’s “can I even access medication at all,” or “how do I survive the waitlist”.

This page abandons theoretical scenarios to address the actual reality of transgender healthcare globally.


It is a statistical reality that a massive percentage of the global trans feminine population uses hormone replacement therapy outside of immediate medical supervision. The barriers to access vary by region, but the end result is often the same: DIY (self-medicating).

In the United Kingdom, attempting to access gender-affirming care through the NHS Gender Identity Clinics (GIC) frequently results in staggering wait times—often 3 to 5 years, or more, merely for a first appointment.

  • Many are pushed toward private providers (like GenderCare or GenderGP), which carry significant financial burdens.
  • This bottleneck forces thousands into self-medicating while trapped in the queue, creating a massive, underserved demographic utilizing grey-market suppliers.

In the United States, healthcare access dramatically shifts depending on where you live and your insurance status.

  • Informed Consent: Many states have excellent “Informed Consent” clinics (such as Planned Parenthood) where HRT can be accessed rapidly without requiring a therapist’s letter. Telehealth services like Plume or Folx have also lowered the logistical barrier.
  • The Political Landscape: However, an increasing number of states have enacted legislative bans or severe restrictions on gender-affirming care, particularly for minors, forcing families to cross state lines or pivot to unregulated online markets.
  • Financial Barriers: Medical gatekeeping and the sheer cost of US healthcare remain massive hurdles for uninsured individuals.

Because of gatekeeping, waitlists, and legal hostility, the “DIY” (Do-It-Yourself) or grey-market HRT community is massive. Trans women globally source medications from overseas pharmacies, cryptocurrency-based homebrew suppliers, or independent distributors.


If you are in a region where it is permitted, seeking an Informed Consent clinic is always the best primary option. They do not require a psychiatric evaluation or a “real-life experience” test; they simply inform you of the effects and risks of HRT and prescribe the medication.

→ Community Resources for Finding Clinics

If you are in the US, Erin’s Informed Consent HRT Map is a community-maintained resource showing hundreds of clinics operating on the informed consent model nationwide.

In the UK, resources like GenderKit provide crucial navigational hubs for surviving the GIC system or moving to private endocrinology.


If you are self-medicating, you cannot skip blood tests. Accessing labs without a doctor’s order is entirely possible in many countries.

  • In the US: Services like PrivateMDLabs or WalkInLab allow you to independently purchase a lab requisition online. You take the printout directly to a local Quest Diagnostics or LabCorp. Nobody evaluates your gender presentation; they just draw the blood and email you the results.
  • In the UK: Private blood testing services like Medichecks offer both finger-prick kits and venous draw options (via specialized clinics).

Your “Baseline” and routine checks should include at minimum:

  1. Estradiol (E2)
  2. Total Testosterone (T)
  3. Comprehensive Metabolic Panel (CMP) (to check liver enzymes AST/ALT, and potassium if using Spironolactone)
  4. Prolactin (if using Cyproterone Acetate)

Total cost usually ranges from $60 to $150 USD, depending on the provider and the breadth of the panel.

The Hack: Tell the phlebotomist absolutely nothing. You purchased a blood panel for “general health monitoring.” Hand them the requisition, get the draw, and read the results yourself using our Blood Tests Guide.


§ 8.4 The Safety Baseline: Rules for the Unsupervised

섹션 제목: “§ 8.4 The Safety Baseline: Rules for the Unsupervised”

Baseline Rule 1: Get Bloodwork Before You Start

섹션 제목: “Baseline Rule 1: Get Bloodwork Before You Start”

You must know your starting point. You need to verify your liver is healthy and you don’t possess a preexisting clotting disorder before throwing sex hormones into the mix. If you have been DIYing for months without a single blood test—stop delaying and buy a panel today.

The core principle across all international guidelines is “use the lowest effective dose” [1] [3] .

  • Do not start at 6mg of oral estradiol. Start at 2mg.
  • Do not start Cyproterone at 50mg. Start at 12.5mg (or less).
  • Wait a full 4 weeks minimum before re-testing and evaluating an increase.

Baseline Rule 4: Identify Emergency Danger Signals

섹션 제목: “Baseline Rule 4: Identify Emergency Danger Signals”

If you experience any of the following, stop your medication immediately and proceed to an emergency room:

SymptomPotential CauseUrgency
Swelling, heat, or severe pain in ONE calfDeep Vein Thrombosis (DVT)Immediate ER
Sudden chest pain / shortness of breathPulmonary Embolism (PE)Immediate ER
Yellowing skin/eyes (Jaundice)Hepatotoxicity/Liver FailureImmediate ER
Sudden severe migraine with vision changesStroke / MeningiomaImmediate ER
Muscle spasms, numbness, weakness (If on Spiro)Hyperkalemia (High Potassium)Urgent Doctor Visit
Severe suicidal ideationPsychological CrisisCall a Hotline Now

The state of global transgender healthcare is frequently dismal. Medical gatekeeping, astronomical costs, and political weaponization have cornered the community into taking medical matters into their own hands.

However, being forced off the grid does not mean you have to be reckless.

  • If you haven’t started — Read our Before You Start guide and get your baseline bloodwork.
  • If you are DIYing blind — Get a private lab test immediately (see §8.3).
  • If you have access — Find an Informed Consent provider and get legal, monitored prescriptions.

You deserve safe, competent medical care. Until the world catches up and provides it, please protect yourself using data, patience, and caution.


References

  1. Hembree WC et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. J Clin Endocrinol Metab 2017;102(11):3869-3903.
  2. Coleman E et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health 2022;23(S1):S1-S259.
  3. Deutsch MB. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. UCSF, 2016.